T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Journal article
Ogbe A. et al, (2021), Nature Communications, 12
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Journal article
Payne RP. et al, (2021), Cell
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22
MAIT cell activation augments adenovirus vector vaccine immunogenicity
Journal article
Provine NM. et al, (2021), Science, 371, 521 - 526
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
Working paper
Thompson CP. et al, (2020), Eurosurveillance, 25
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
Journal article
Slevin SM. et al, (2020), Journal of Crohn's and Colitis, 14, 1446 - 1461
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
Journal article
Sasson SC. et al, (2020), Clinical and experimental immunology
MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.
Journal article
Esposito I. et al, (2020), Science translational medicine, 12
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Journal article
Cicconi P. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70, 2073 - 2081
MAIT Cells in Health and Disease.
Journal article
Provine NM. and Klenerman P., (2020), Annual review of immunology, 38, 203 - 228
Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus.
Journal article
Fawsitt CG. et al, (2020), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23, 180 - 190
Local heroes or villains: tissue-resident memory T cells in human health and disease.
Journal article
Sasson SC. et al, (2020), Cell Mol Immunol
Human MAIT Cell Activation In Vitro.
Journal article
Hagel JP. et al, (2020), Methods in molecular biology (Clifton, N.J.), 2098, 97 - 124
HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
Journal article
McNaughton AL. et al, (2019), BMC Medicine, 17
Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.
Journal article
Luo J. et al, (2019), The Journal of allergy and clinical immunology, 144, 1722 - 1726.e10
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).
Journal article
Cossarizza A. et al, (2019), European journal of immunology, 49, 1457 - 1973
Prolonged evolution of virus-specific memory T cell immunity after severe avian influenza A (H7N9) virus infection
Conference paper
Zhao M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1045 - 1045
Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis
Conference paper
Sasson SC. et al, (2019), ANNALS OF ONCOLOGY, 30, 530 - 530
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
Journal article
Ansari MA. et al, (2019), eLife, 8